Sentry LLC’s GSK GSK Stock Holding History

Sentry LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$391K	Hold	7,468	–	–	0.11%	84
2026 Q1	$412K	Hold	7,468	–	–	0.13%	79
2025 Q4	$366K	Hold	7,468	–	–	0.1%	88
2025 Q3	$322K	Hold	7,468	–	–	0.08%	96
2025 Q2	$287K	Hold	7,468	–	–	0.06%	101
2025 Q1	$289K	Hold	7,468	–	–	0.06%	97
2024 Q4	$253K	Hold	7,468	–	–	0.05%	105
2024 Q3	$305K	Hold	7,468	–	–	0.06%	98
2024 Q2	$288K	Hold	7,468	–	–	0.05%	97
2024 Q1	$320K	Hold	7,468	–	–	0.06%	93
2023 Q4	$277K	Hold	7,468	–	–	0.06%	95
2023 Q3	$271K	Hold	7,468	–	–	0.06%	98
2023 Q2	$266K	Hold	7,468	–	–	0.06%	103
2023 Q1	$266K	Buy	+7,468	New	+$261K	0.06%	98

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sentry LLC's GSK Position: Q2 2026 in Review

Sentry LLC held its GSK (GSK) position steady in Q2 2026 at 7,468 shares worth $391K. The position accounts for 0.11% of the portfolio, ranked #84.

Sentry LLC first reported a position in GSK in Q1 2023 and has held it in 14 quarters since. The position peaked at $412K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Sentry LLC held 7,468 shares of GSK worth $391K as of Q2 2026.
Sentry LLC left its GSK share count unchanged in Q2 2026.
GSK made up 0.11% of Sentry LLC's portfolio in Q2 2026, its #84 holding.
Sentry LLC first reported a position in GSK in Q1 2023 and has held it in 14 quarters since.
Sentry LLC's GSK position peaked at $412K in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sentry LLC's 13F filing for Q2 2026, filed 14 Aug 2026.